Guselkumab versus secukinumab for the treatment of moderate-to-severe psoriasis (ECLIPSE): results from a phase 3, randomised controlled trial

Kristian Reich, April W. Armstrong, Richard G. Langley, Susan Flavin, Bruce Randazzo, Shu Li, Ming Chun Hsu, Patrick Branigan, Andrew Blauvelt

Research output: Contribution to journal › Article › peer-review

268 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Guselkumab versus secukinumab for the treatment of moderate-to-severe psoriasis (ECLIPSE): results from a phase 3, randomised controlled trial'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Immunology and Microbiology

Pharmacology, Toxicology and Pharmaceutical Science